Methylmalonic acidemia: Neurodevelopment and neuroimaging

Methylmalonic acidemia (MMA) is a genetic disease of abnormal organic acid metabolism, which is one of the important factors affecting the survival rate and quality of life of newborns or infants. Early detection and diagnosis are particularly important. The diagnosis of MMA mainly depends on clinical symptoms, newborn screening, biochemical detection, gene sequencing and neuroimaging diagnosis. The accumulation of methylmalonic acid and other metabolites in the body of patients causes brain tissue damage, which can manifest as various degrees of intellectual disability and severe neurological dysfunction. Neuroimaging examination has important clinical significance in the diagnosis and prognosis of MMA. This review mainly reviews the etiology, pathogenesis, and nervous system development, especially the neuroimaging features of MMA.

• Publication year

  2023

• Venue

  Frontiers in Neuroscience

• Publication date

  2023-01-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.3389/fnins.2023.1110942PMID 36777632PMCID 9909197
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Review of neuropsychological outcomes in isolated methylmalonic acidemia: recommendations for assessing impact of treatments

  2022cited by this paper
• Toxic Metabolites and Inborn Errors of Amino Acid Metabolism: What One Informs about the Other

  2022cited by this paper
• The Follow-Up of Chinese Patients in cblC Type Methylmalonic Acidemia Identified Through Expanded Newborn Screening

  2022influential reference
• Determination of Cytokines and Oxidative Stress Biomarkers in Cognitive Impairment Induced by Methylmalonic Acidemia

  2021cited by this paper
• Clinical features and outcomes of patients with cblC type methylmalonic acidemia carrying MMACHC gene c . 609G>A mutation

  2021cited by this paper
• Prenatal diagnosis of combined methylmalonic acidemia and homocystinuria cobalamin C type using clinical exome sequencing and targeted gene analysis

  2021cited by this paper
• Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: First revision

  2021cited by this paper
• Clinical features and outcomes of patients with cblC type methylmalonic acidemia carrying gene c.609G>A mutation.

  2021cited by this paper
• Prevalence of the most common pathogenic variants in three genes for inborn errors of metabolism associated with sudden unexpected death in infancy: a population-based study in south Brazil

  2020cited by this paper
• High protein prescription in methylmalonic and propionic acidemia patients and its negative association with long-term outcome.

  2020cited by this paper
• Novel imaging technologies for genetic diagnoses in the inborn errors of metabolism

  2020cited by this paper
• Methylmalonic acidemia: Current status and research priorities.

  2018cited by this paper
• Methylmalonate Induces Inflammatory and Apoptotic Potential: A Link to Glial Activation and Neurological Dysfunction

  2017cited by this paper
• Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency

  2016cited by this paper
• Impact of age at onset and newborn screening on outcome in organic acidurias

  2016cited by this paper
• Ammonium accumulation is a primary effect of 2-methylcitrate exposure in an in vitro model for brain damage in methylmalonic aciduria.

  2016cited by this paper
• Methylmalonic and propionic acidemias: clinical management update

  2016cited by this paper
• Insights into the molecular mechanisms of methylmalonic acidemia using microarray technology.

  2015cited by this paper
• Optic neuropathy in methylmalonic acidemia and propionic acidemia

  2015cited by this paper
• Clinical features and MUT gene mutation spectrum in Chinese patients with isolated methylmalonic acidemia: identification of ten novel allelic variants

  2015cited by this paper
• MRI Characteristics of Globus Pallidus Infarcts in Isolated Methylmalonic Acidemia

  2015cited by this paper
• The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype

  2015cited by this paper
• Adult-onset renal thrombotic microangiopathy and pulmonary arterial hypertension in cobalamin C deficiency.

  2015cited by this paper
• Current status of newborn screening worldwide: 2015.

  2015cited by this paper
• Clinical presentation and outcome in a series of 88 patients with the cblC defect

  2014influential reference
• Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia

  2014cited by this paper
• Long-term visual outcome of methylmalonic aciduria and homocystinuria, cobalamin C type.

  2014cited by this paper
• Brain damage in methylmalonic aciduria: 2-methylcitrate induces cerebral ammonium accumulation and apoptosis in 3D organotypic brain cell cultures

  2013cited by this paper
• Neurologic and neurodevelopmental phenotypes in young children with early-treated combined methylmalonic acidemia and homocystinuria, cobalamin C type.

  2013influential reference
• Neurocognitive Phenotype of Isolated Methylmalonic Acidemia

  2012cited by this paper
• Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management

  2012cited by this paper
• Cobalamin C defect: natural history, pathophysiology, and treatment

  2011cited by this paper
• Mutation spectrum of MMACHC in Chinese patients with combined methylmalonic aciduria and homocystinuria

  2010cited by this paper
• Fractional anisotropy for assessment of white matter tracts injury in methylmalonic acidemia.

  2009cited by this paper
• Looking beyond the basal ganglia: The spectrum of MRI changes in methylmalonic acidaemia

  2008cited by this paper
• MR appearance in pediatric patients with methylmalonic aciduria

  2008cited by this paper
• MR Imaging of the Brain in Methylmalonic Aciduria and Propionic Aciduria

  2008cited by this paper
• Methylmalonic acidemia: brain imaging findings in 52 children and a review of the literature

  2008cited by this paper
• [Clinical studies on fifty-seven Chinese patients with combined methylmalonic aciduria and homocysteinemia].

  2007cited by this paper
• The adolescent and adult form of cobalamin C disease: clinical and molecular spectrum

  2007influential reference
• Late‐onset combined homocystinuria and methylmalonic aciduria (cblC) and neuropsychiatric disturbance

  2007influential reference
• Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia

  2006cited by this paper
• Spectrum of mutations in mut methylmalonic acidemia and identification of a common Hispanic mutation and haplotype

  2006cited by this paper
• Subacute combined degeneration of the spinal cord in cblC disorder despite treatment with B12.

  2006influential reference
• Combined methylmalonic aciduria and homocystinuria (cblC): phenotype-genotype correlations and ethnic-specific observations.

  2006cited by this paper
• Magnetic resonance imaging and diffusion‐weighted imaging in methylmalonic acidemia

  2005cited by this paper
• MRI and 1H‐MRS Findings in Early-Onset Cobalamin C/D Defect

  2005cited by this paper
• [Diagnosis and treatment of methylmalonic acidemia in 14 cases].

  2004cited by this paper
• Imaging of the brain, including diffusion-weighted imaging in methylmalonic acidemia

  2004cited by this paper
• The Basal Ganglia and involuntary movements: impaired inhibition of competing motor patterns.

  2003cited by this paper
• Diffusion-weighted imaging in the assessment of neurological damage in patients with methylmalonic aciduria

  2003cited by this paper
• Methylmalonic Acid, a Biochemical Hallmark of Methylmalonic Acidurias but No Inhibitor of Mitochondrial Respiratory Chain*

  2003cited by this paper
• Magnetic Resonance Imaging and Spectroscopy in a Patient with Treated Methylmalonic Acidemia

  2003cited by this paper
• Hyperhomocysteinemia: a new risk factor for degenerative diseases.

  2002cited by this paper
• Neurodegeneration in Methylmalonic Aciduria Involves Inhibition of Complex II and the Tricarboxylic Acid Cycle, and Synergistically Acting Excitotoxicity*

  2002cited by this paper
• Early-onset combined methylmalonic aciduria and homocystinuria: neuroradiologic findings.

  2001cited by this paper
• Multi-slice proton MR spectroscopy and diffusion-weighted imaging in methylmalonic acidemia: report of two cases and review of the literature.

  2001cited by this paper
• Clinical and brain 18fluoro-2-deoxyglucose positron emission tomographic findings in ethylmalonic aciduria, a progressive neurometabolic disease.

  1999cited by this paper
• A new view on the CSF‐circulation with the potential for pharmacological treatment of childhood hydrocephalus

  1997cited by this paper
• CT and MR of the brain in disorders of the propionate and methylmalonate metabolism.

  1994cited by this paper
• Metabolic stroke in methylmalonic acidemia.

  1989cited by this paper
• The natural history of the inherited methylmalonic acidemias.

  1983cited by this paper

• Polymer of methyl malonic acid suppress inflammation by downregulating IL-2 through ROS overproduction

  2026cites this paper
• Unveiling clinical and genetic landscapes of MMA and CBS: insights from whole exome sequencing in a tertiary care setting.

  2026cites this paper
• Aldehyde dehydrogenase family 6A1 restores implant osseointegration in hyperlipidemia by disrupting ROS-ERS-LPO vicious cycle and reestablishing adhesion-osteogenesis coupling.

  2026cites this paper
• The emerging role of dysregulated propionate metabolism and methylmalonic acid in metabolic disease, aging, and cancer.

  2025cites this paper
• Costunolide Ameliorates the Methylmalonic Acidemia Via the PINK1/Parkin Pathway

  2025cites this paper
• Unlocking the mystery: Methylmalonic aciduria masquerading as Guillain–Barre syndrome

  2025cites this paper
• Correlation between toxic organic acid fluctuations and neurodevelopment in patients with methylmalonic acidemia

  2025cites this paper
• Oxidative stress in branched-chain organic acidemias using thiol-disulfide homeostasis

  2025cites this paper
• Fatal Case Report of Methylmalonic Acidemia: Reflections on Organic Acidemias in Colombia

  2025cites this paper
• Hydrocephalus Caused by Methylmalonic Acidemia: Clinical Characteristics, Optimal Timing of Surgical Intervention and Health-Related Quality of Life

  2025cites this paper
• Recent Advances in mRNA-LNP Delivery Systems for Extrahepatic Organs: A Review.

  2025cites this paper
• Clinical and molecular spectrum of patients with methylmalonic acidemia and homocysteinemia complicated by cardiovascular manifestations

  2025cites this paper
• First pathogenic non-coding variant in MMACHC: a functional deletion in the 5′-UTR associated with cobalamin C deficiency

  2025cites this paper
• Selenium and Brain Aging: A Comprehensive Review with a Focus on Hippocampal Neurogenesis.

  2025cites this paper
• Serum Proteome Profiling Implicates Dysregulation of Immune Response and Inflammatory Mechanisms in Methylmalonic Acidemia With Brain Injury

  2025cites this paper
• Retrospective analysis of diagnosis and treatment in 9 cases of childhood-onset methylmalonic acidemia in China

  2025cites this paper
• Magnetic resonance imaging features and neurodevelopmental prognosis in infants diagnosed with organic acidaemia.

  2025cites this paper
• Case Report: Cerebellar microhemorrhages: an underrecognized feature of MMA-HC revealed by high-field 7.0 T MRI

  2025cites this paper
• Metabolic toxicity and neurological dysfunction in methylmalonic acidemia: from mechanisms to therapeutics

  2025cites this paper
• Mitochondrial dysfunction in methylmalonic acidemia: A pilot study using Seahorse technology in peripheral blood

  2025cites this paper
• Biotin-Thiamine-Responsive Basal Ganglia Disease: A Case Report

  2024cites this paper
• Organic Acidemias: Clinical Presentation in Neonates

  2024cites this paper
• Human Glycolysis Isomerases are Inhibited by Weak Metabolite Modulators

  2024cites this paper
• Associations between elevated uric acid and brain imaging abnormalities in pediatric patients with methylmalonic acidemia under 5 years of age

  2024cites this paper
• Clinical spectrum and genetic variation of six patients with methylmalonic aciduria (MMA); a report from Iran

  2024cites this paper
• A genome-wide investigation into the underlying genetic architecture of personality traits and overlap with psychopathology

  2024cites this paper
• Clinical and electroencephalogram characteristics of methylmalonic acidemia with MMACHC and MUT gene mutations

  2024cites this paper
• mRNA biotherapeutics landscape for rare genetic disorders

  2024cites this paper
• Improving the second-tier classification of methylmalonic acidemia patients using a machine learning ensemble method

  2024cites this paper
• A Case of Adult cbc1 Type Methylmalonic Acidemia with Peripheral Neuropathy as the Main Manifestation

  2024cites this paper
• Concurrent combined methylmalonic acidemia and homocystinuria with down syndrome in a Chinese preschool Child: An in-depth case report and literature review

  2024cites this paper
• Using metabolic abnormalities of carriers in the neonatal period to evaluate the pathogenicity of variants of uncertain significance in methylmalonic acidemia

  2024cites this paper
• Long‐Term Outcomes of Living Donor Liver Transplantation for Methylmalonic Acidemia

  2024cites this paper
• A genome-wide investigation into the underlying genetic architecture of personality traits and overlap with psychopathology

  2024cites this paper
• Dysregulation of cerebrospinal fluid metabolism profiles in spinal muscular atrophy patients: a case control study

  2024influential citation
• Disruption of Mitochondrial Quality Control in Inherited Metabolic Disorders

  2024cites this paper
• Immune remodulation in pediatric inherited metabolic liver diseases

  2024cites this paper
• Methylmalonic acid in aging and disease.

  2023cites this paper
• Late-onset cobalamin C deficiency type in adult with cognitive and behavioral disturbances and significant cortical atrophy and cerebellar damage in the MRI: a case report

  2023cites this paper
• Clinical and electroencephalogram characteristics of methylmalonic acidemia with neurological injury

  year unknowncites this paper